Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

SOD1 Inhibition by Pyrimethamine in Familial Amyotrophic Lateral Sclerosis (ALS)

This study has been completed.
Muscular Dystrophy Association
Information provided by (Responsible Party):
Dr. Dale J. Lange, Weill Medical College of Cornell University Identifier:
First received: December 17, 2009
Last updated: August 14, 2016
Last verified: August 2016
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: May 2016
  Primary Completion Date: December 2014 (Final data collection date for primary outcome measure)